TABLE 2.
Cohort Demographics and Diagnoses
| Race | Sample Size: No. (%) | Women, % | Age at Diagnosis, %
|
Disease Stage, %
|
CCI Score 6 Mo Before Diagnosis, %
|
|||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 65–69 Y | 70–74 Y | 75–79 Y | ≥80 Years | I | II | III | 0 | 1 | ≥2 | |||
| Breast cancer | ||||||||||||
| AI/AN | 216 (0.24) | 100 | 25.9 | 25.9 | 24.1 | 24.1 | 50.9 | 39.8 | 9.3 | 61.5 | 23.5 | 15 |
| White | 76,185 (86.1) | 99.1 | 23.1 | 24.1 | 23.9 | 29 | 57.2 | 35.8 | 7 | 74.5 | 18.3 | 7.2 |
| Colon cancer | ||||||||||||
| AI/AN | 211 (0.3) | 61.6 | 22.8 | 27.5 | 20.9 | 28.9 | 25.6 | 42.2 | 32.2 | 53.1 | 26.6 | 20.3 |
| White | 58,318 (83) | 55.2 | 16.3 | 20.4 | 23.5 | 39.8 | 30.2 | 40.4 | 29.4 | 57 | 26.8 | 16.2 |
| Prostate cancer | ||||||||||||
| AI/AN | 279 (0.27) | 0 | 42.3 | 26.5 | 20.4 | 10.8 | 40.1 | 44.1 | 15.8 | 68.4 | 20.5 | 11.1 |
| White | 80,654 (78.1) | 0 | 31.5 | 30.2 | 22.8 | 15.5 | 48.3 | 41.5 | 10.2 | 76.7 | 16.4 | 6.9 |
| Lung cancer | ||||||||||||
| AI/AN | 211 (0.28) | 44.1 | 29.4 | 24.6 | 23.7 | 22.3 | 36 | 9.5 | 54.5 | 33 | 39.6 | 27.4 |
| White | 64,240 (84.4) | 48 | 23.5 | 26.7 | 25.3 | 24.6 | 41.2 | 6.7 | 52.1 | 40.4 | 37.3 | 22.4 |
Abbreviations: AI/AN, American Indian/Alaskan Native; CCI, Charlson comorbidity index.